Nucleic Acid Aptamers as Novel Class of Therapeutics to Mitigate Alzheimer's Disease Pathology

Rudi K. Tannenberg, Hadi Al. Shamaileh, Lasse Holm Lauridsen, Jagat R. Kanwar, Peter R. Dodd, Rakesh N. Veedu

Research output: Contribution to journalJournal articleResearchpeer-review

Fingerprint

Dive into the research topics of 'Nucleic Acid Aptamers as Novel Class of Therapeutics to Mitigate Alzheimer's Disease Pathology'. Together they form a unique fingerprint.

Medicine & Life Sciences